Investor's Business Daily on MSN
How S&P drug titan Pfizer plans to outdo its own $6 billion franchise
The next-generation version of Pfizer's $6 billion pneumococcal vaccine franchise topped its predecessor in a midstage study.
An oral drug from Pfizer causes a similar amount of weight loss as the blockbuster Ozempic injection, made by rival Novo Nordisk, according to results from a phase two clinical trial. The results were ...
Pfizer hasn't yet tapped into the highly lucrative market of diabetes drugs that have been increasingly used for weight loss purposes. Searching for a weight-loss drug but don't like the idea of an ...
(RTTNews) - Hospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection Carpuject Units, ...
The pharmaceutical powerhouse still faces plenty of patent challenges, but it got a big one out of the way, securing time and ...
Searching for a weight-loss drug but don't like the idea of an injection? Pfizer may soon be able to help. The pharmaceutical company announced Thursday it's advancing development of its GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results